Sector Reports on Investment Opportunities in Health and Medicine Featured at 5th Annual OneMedForum
OneMedPlace announced today that OneMedForum San Francisco 2012 will feature special reports in 8 healthcare sectors.
The Wallace H. Coulter Foundation Optimizes Academia Process
“We have very clear timelines, milestones, and we define the critical experiment that, if it’s successful will bring value to the technology and make it ready for follow-up funding.”
Vasomedical Proves Itself A Company To Watch On The Fast Track to Growth
With the recent acquisition of the two Chinese companies, restructuring, and the addition of a new CFO, Vasomedical is now positioned to move forward and further implement plans for expansion and growth.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
NeoStem Expected To Have Short and Long Term Value Drivers
NeoStem has transformed itself over the last year and half with two acquisitions, multiple financings and their expansion into China.
Citigroup Pricing The Offering of GSVC [NASDAQ:GSVC] Later This Week
Citigroup [NYSE:CITI] pricing GSVC’s $100 million raise this week. As of end of trading Sept 19th, GSVC stock is trading at about $14.37 and seems undervalued for several reasons.
Editor’s Note September 19, 2011
OneMedSentinel is pleased to bring you another round of stories and interviews with some of the most promising companies and technologies, as well as innovative […]
ImmunoGenetix Discovers a Safer Approach To HIV Treatment
James Laufenberg, CEO of ImmunoGenetix was interviewed by OneMedRadio where he discussed a therapeutic DNA based composition to treat HIV, GenePro.
September 27-28, 2011 Jeffries Global Healthcare Conference London
We are pleased to announce Jefferies 2011 Global Healthcare Conference taking place 27-28 September, 2011 in London, UK.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.